Detalhe da pesquisa
1.
In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer.
J Enzyme Inhib Med Chem
; 38(1): 2166039, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36683274
2.
Identification of a dual FLT3 and MNK2 inhibitor for acute myeloid leukemia treatment using a structure-based virtual screening approach.
Bioorg Chem
; 121: 105675, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35182882
3.
Investigation of Selected Flavonoid Derivatives as Potent FLT3 Inhibitors for the Potential Treatment of Acute Myeloid Leukemia.
J Nat Prod
; 84(1): 1-10, 2021 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33393294
4.
The Antileukemic Effect of Xestoquinone, A Marine-Derived Polycyclic Quinone-Type Metabolite, Is Mediated through ROS-Induced Inhibition of HSP-90.
Molecules
; 26(22)2021 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34834129
5.
Biological Evaluation of Selected Flavonoids as Inhibitors of MNKs Targeting Acute Myeloid Leukemia.
J Nat Prod
; 83(10): 2967-2975, 2020 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33026809
6.
Establishment of extensive artificial intelligence models for kinase inhibitor prediction: Identification of novel PDGFRB inhibitors.
Comput Biol Med
; 156: 106722, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878123
7.
In silico prediction of immune-escaping hot spots for future COVID-19 vaccine design.
Sci Rep
; 13(1): 13468, 2023 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37596329
8.
Fluoropyrimidin-2,4-dihydroxy-5-isopropylbenzamides as antitumor agents against CRC and NSCLC cancer cells.
Eur J Med Chem
; 203: 112540, 2020 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32683166